Non‐alcoholic fatty liver disease independently predicts prediabetes during a 7‐year prospective follow‐up
- 8 May 2013
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 33 (9) , 1406-1412
Abstract
Background & Aims: Non‐alcoholic fatty liver disease (NAFLD) is suspected to confer an increased risk for developing type 2 diabetes (DM). However, only a few prospective studies evaluated NAFLD as a predictor for DM, most did not adjust for the full range of potential cofounders and none used an objectively quantified degree of steatosis. Our aim was to evaluate the independent role of NAFLD in predicting the development of pre‐DM in a 7‐year prospective follow‐up of healthy volunteers.Methods: A prospective cohort of a subsample of the Israeli National Health Survey evaluated at baseline and after 7 years by identical protocols. Metabolic parameters and ultrasonographic evidence of NAFLD were evaluated in 213 subjects, without known liver disease or history of alcohol abuse. Exclusion criteria were pre‐DM at the baseline survey. Steatosis was quantified by ultrasound with the hepato‐renal ultrasound index (HRI).Results: The study included 141 volunteers (mean age 48.78 ± 9.68, 24.82% with NAFLD) without pre‐DM/DM at baseline. Both NAFLD on regular US (OR=2.93, 1.02–8.41 95%CI) and HRI (OR=7.87, 1.83–33.82) were independent predictors for the development of pre‐DM, adjusting for age, gender, BMI, family history of DM, baseline insulin, adiponectin and glucose. Further adjustment for physical activity and dietary intake did not weaken the association. Furthermore, NAFLD was a stronger predictor for pre‐DM than the metabolic syndrome. Subjects with both NAFLD and glucose ≥89 had 93.3% incidence rate of pre‐DM.Conclusion: Non‐alcoholic fatty liver disease is a strong and independent risk factor for pre‐DM in the general adult population; thus, NAFLD patients should be classified as a population at risk.Keywords
This publication has 50 references indexed in Scilit:
- Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes StudyThe Lancet, 2012
- Prevalence and trends of the diabetes epidemic in South Asia: a systematic review and meta-analysisBMC Public Health, 2012
- Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver as Risk Factors for Type 2 DiabetesDiabetes Care, 2012
- Cellular mechanism of insulin resistance in nonalcoholic fatty liver diseaseProceedings of the National Academy of Sciences, 2011
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011
- Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes StudyDiabetes Care, 2011
- Interrelationship between Fatty Liver and Insulin Resistance in the Development of Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2011
- A position statement on NAFLD/NASH based on the EASL 2009 special conferenceJournal of Hepatology, 2010
- Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. studyBMC Gastroenterology, 2010
- Alanine Aminotransferase, γ-Glutamyltransferase, and Incident DiabetesDiabetes Care, 2009